Duravent PE by is a Otc medication manufactured, distributed, or labeled by Allegis Pharmaceuticals, LLC. Drug facts, warnings, and ingredients follow.
DURAVENT PE- guaifenesin and phenylephrine hydrochloride tablet
Allegis Pharmaceuticals, LLC
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
Do not exceed recommended dosage.
Do not exceed recommended dosage.
Adults and Children 12 years of age and older: | 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours |
Childen 6 to under 12 years of age: | ½ tablet every 4 hours, not to exceed 3 tablets in 24 hours |
Children under 6 years of age: | Consult a physician. |
Store at 15°-30° C (59°-86° F).
Tamper evident by foil seal under cap.
Do not use if foil seal is missing or broken.
Dispense in a tight, light-resistant container with a child resistant cap.
colloidal silicon dioxide, croscarmellose sodium, FD&C Blue #1 aluminum lake, hypromellose, maltodextrin, povidone, sillicified microcrystalline cellulose, and stearic acid.
NDC: 28595-905-60
Expectorant Nasal Decongestant
DURAVENT™PE
Each tablet contains:
Guaifenesin 395 mg
Phenylephrine HCl 10 mg
Tamper evident by foil seal under cap.
Do not use if foil seal is broken or missing.
Manufactured for: Allegis Pharmaceuticals, LLC
Canton, MS 39046
60 Tablets
DURAVENT PE
guaifenesin and phenylephrine hydrochloride tablet |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Allegis Pharmaceuticals, LLC (792272861) |